Comparison between placental gene expression of 11β-hydroxysteroid dehydrogenases and infantile growth at 10 months of age

Journal of Obstetrics and Gynaecology Research

Volumn 40, Issue 2, 2014, Pages 465-472

  Muramatsu Kato, Keiko ^a   Itoh, Hiroaki ^a   Kobayashi Kohmura, Yukiko ^a   Murakami, Hirotake ^a   Uchida, Toshiyuki ^a   Suzuki, Kazunao ^a   Sugihara, Kazuhiro ^a   Kanayama, Naohiro ^a   Tsuchiya, Kenji J ^a   Takei, Nori ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glucocorticoid; Growth; Infant; Placenta; Pregnancy; Programming

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ADIPOCYTOKINE; ADIPONECTIN; HYDROCORTISONE; LEPTIN; MESSENGER RNA;

ADULT; ARTICLE; BIRTH; BIRTH WEIGHT; BODY WEIGHT; CESAREAN SECTION; CHILD GROWTH; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; INFANT; PLACENTA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; BLOOD; CHILD DEVELOPMENT; FETUS BLOOD; GENETICS; METABOLISM; MIDDLE AGED; PREGNANCY; TIME; YOUNG ADULT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADIPONECTIN; ADULT; BODY WEIGHT; CHILD DEVELOPMENT; FEMALE; FETAL BLOOD; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; HYDROCORTISONE; INFANT; LEPTIN; MIDDLE AGED; PLACENTA; PREGNANCY; RNA, MESSENGER; TIME FACTORS; YOUNG ADULT;

EID: 84898003731     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12200     Document Type: Article

References (34)

1. Munck A, Naray-Fejes-Toth A. The ups and downs of gluco-corticoid physiology. Permissive and suppressive effects revisited. Mol Cell Endocrinol 1992; 90: C1-C4.
2. Funder JW, Krozowski Z, Myles K, Sato A, Sheppard KE, Young M. Mineralocorticoid receptors, salt, and hypertension. Recent Prog Horm Res 1997; 52: 247-260; discussion 261-2.
3. Monder C, White PC. 11 beta-hydroxysteroid dehydrogenase. Vitam Horm 1993; 47: 187-271.
4. Michael AE, Thurston LM, Rae MT. Glucocorticoid metabolism and reproduction: A tale of two enzymes. Reproduction 2003; 126: 425-441.
5. Shams M, Kilby MD, Somerset DA et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998; 13: 799-804.
6. Campbell AL, Murphy BE. The maternal-fetal cortisol gradient during pregnancy and at delivery. J Clin Endocrinol Metab 1977; 45: 435-440.
7. McMullen S, Osgerby JC, Thurston LM et al. Alterations in placental 11 beta-hydroxysteroid dehydrogenase (11 betaHSD) activities and fetal cortisol: cortisone ratios induced by nutritional restriction prior to conception and at defined stages of gestation in ewes. Reproduction 2004; 127: 717-725.
8. Bevilacqua E, Brunelli R, Anceschi MM. Review and meta-analysis: Benefits and risks of multiple courses of antenatal corticosteroids. J Matern Fetal Neonatal Med 2010; 23: 244-260.
9. Struwe E, Berzl GM, Schild RL et al. Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates. Am J Obstet Gynecol 2007; 197: 43.e1-43.e6.
10. Mericq V, Medina P, Kakarieka E, Marquez L, Johnson MC, Iniguez G. Differences in expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender. Eur J Endocrinol 2009; 161: 419-425.
11. McTernan CL, Draper N, Nicholson H et al. Reduced placen-tal 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: An analysis of possible mechanisms. J Clin Endocrinol Metab 2001; 86: 4979-4983.
12. Kajantie E, Dunkel L, Turpeinen U et al. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 2003; 88: 493-500.
13. Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrau-terine growth Restriction: Evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta 2008; 29: 193-200.
14. Stewart PM, Rogerson FM, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: Its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 1995; 80: 885-890.
15. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 2002; 87: 1660-1668.
16. Rogerson FM, Kayes KM, White PC. Variation in placental type 2 11beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol Cell Endo-crinol 1997; 128: 103-109.
17. Tamashiro KL, Moran TH. Perinatal environment and its influences on metabolic programming of offspring. Physiol Behav 2010; 100: 560-566.
18. Drake AJ, Tang JI, Nyirenda MJ. Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci (Lond) 2007; 113: 219-232.
19. Tsuchiya KJ, Matsumoto K, Suda S et al. Searching for very early precursors of autism spectrum disorders: The Hamamatsu Birth Cohort for Mothers and Children (HBC). J Dev Orig Health Dis 2010; 1: 158-173.
20. Malendowicz LK, Rucinski M, Belloni AS, Ziolkowska A, Nussdorfer GG. Leptin and the regulation of the hypothalamic-pituitary-adrenal axis. Int Rev Cytol 2007; 263: 63-102.
21. Lee MJ, Fried SK. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. Am J Physiol Endocrinol Metab 2009; 296: E1230-E1238.
22. Schulz C, Paulus K, Lehnert H. Adipocyte-brain: Crosstalk. Results Probl Cell Differ 2010; 52: 189-201.
23. Sukumaran S, Dubois DC, Jusko WJ, Almon RR. Glucocorti-coid effects on adiponectin expression. Vitam Horm 2012; 90: 163-186.
24. Sivan E, Mazaki-Tovi S, Pariente C et al. Adiponectin in human cord blood: Relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003; 88: 5656-5660.
25. Tsai PJ, Yu CH, Hsu SP et al. Cord plasma concentrations of adiponectin and leptin in healthy term neonates: Positive correlation with birthweight and neonatal adiposity. Clin Endo-crinol 2004; 61: 88-93.
26. Karakosta P, Chatzi L, Plana E, Margioris A, Castanas E, Kogevinas M. Leptin levels in cord blood and anthropometric measures at birth: A systematic review and meta-analysis. Paediatr Perinat Epidemiol 2011; 25: 150-163.
27. Nakano Y, Itabashi K, Nagahara K et al. Cord serum adi-ponectin is positively related to postnatal body mass index gain. Pediatr Int 2012; 54: 76-80.
28. Alfaidy N, Xiong ZG, Myatt L, Lye SJ, MacDonald JF, Challis JR. Prostaglandin F2alpha potentiates cortisol production by stimulating 11beta-hydroxysteroid dehydrogenase 1: A novel feedback loop that may contribute to human labor. J Clin Endocrinol Metab 2001; 86: 5585-5592.
29. Murphy VE, Clifton VL. Alterations in human placental 11beta-hydroxysteroid dehydrogenase type 1 and 2 with ges-tational age and labour. Placenta 2003; 24: 739-744.
30. Wyatt SM, Kraus FT, Roh CR, Elchalal U, Nelson DM, Sadovsky Y. The correlation between sampling site and gene expression in the term human placenta. Placenta 2005; 26: 372-379.
31. Yura S, Itoh H, Sagawa N et al. Role of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metab 2005; 1: 371-378.
32. Larsen RJ, Marx ML. An Introduction to Mathematical Statistics and Its Applications, 3rd edn. Upper Saddle River, NJ: Prentice Hall, 2000.
33. Itabashi K, Fujimura M, Kusuda S, Tamura M, Hayashi T, Takahashi T. Introduction of new gestational age-specific standards for birth size. J Jpn Pediatr Soc 2010; 114: 1271-1293.
34. Edwards CR, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucocorticoid barrier: Link between fetal environment and adult hypertension? Lancet 1993; 341: 355-357.